Literature DB >> 20005732

Protein arginine methylation in estrogen signaling and estrogen-related cancers.

Catherine Teyssier1, Muriel Le Romancer, Stéphanie Sentis, Stéphan Jalaguier, Laura Corbo, Vincent Cavaillès.   

Abstract

Estrogen signaling pathways regulate multiple cellular processes including proliferation and differentiation, and dysregulation of these pathways underlies several human pathologies. Post-translational modifications (PTMs) play an important role in estrogen signaling. This review focuses on recent findings pertinent to arginine methylation of non-histone proteins and their implications in estrogen signaling. We describe protein arginine methyltransferases and demethylases, the role of methylarginine proteins in estrogen action and crosstalk with other PTMs such as phosphorylation and lysine methylation. The relationships between various PTMs form a specific code that is likely to play an important role in hormone signaling. In addition, dysregulation of arginine methylation or of enzymes responsible for these modifications could be key events in estrogen-dependent cancers such as breast cancer. Copyright 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20005732     DOI: 10.1016/j.tem.2009.11.002

Source DB:  PubMed          Journal:  Trends Endocrinol Metab        ISSN: 1043-2760            Impact factor:   12.015


  19 in total

Review 1.  Extranuclear signaling by estrogen: role in breast cancer progression and metastasis.

Authors:  V Cortez; M Mann; D W Brann; R K Vadlamudi
Journal:  Minerva Ginecol       Date:  2010-12

Review 2.  Small Molecule Inhibitors of Protein Arginine Methyltransferases.

Authors:  Hao Hu; Kun Qian; Meng-Chiao Ho; Y George Zheng
Journal:  Expert Opin Investig Drugs       Date:  2016-02-16       Impact factor: 6.206

3.  Crystal structure of the plant epigenetic protein arginine methyltransferase 10.

Authors:  Yuan Cheng; Monica Frazier; Falong Lu; Xiaofeng Cao; Matthew R Redinbo
Journal:  J Mol Biol       Date:  2011-10-01       Impact factor: 5.469

Review 4.  Role of PRMTs in cancer: Could minor isoforms be leaving a mark?

Authors:  R Mitchell Baldwin; Alan Morettin; Jocelyn Côté
Journal:  World J Biol Chem       Date:  2014-05-26

5.  Cytoplasmic ERα and NFκB Promote Cell Survival in Mouse Mammary Cancer Cell Lines.

Authors:  Emily Smart; Luis H Alejo; Jonna Frasor
Journal:  Horm Cancer       Date:  2020-02-01       Impact factor: 3.869

Review 6.  Liganded and unliganded activation of estrogen receptor and hormone replacement therapies.

Authors:  Adriana Maggi
Journal:  Biochim Biophys Acta       Date:  2011-05-14

7.  Cell signaling, post-translational protein modifications and NMR spectroscopy.

Authors:  Francois-Xavier Theillet; Caroline Smet-Nocca; Stamatios Liokatis; Rossukon Thongwichian; Jonas Kosten; Mi-Kyung Yoon; Richard W Kriwacki; Isabelle Landrieu; Guy Lippens; Philipp Selenko
Journal:  J Biomol NMR       Date:  2012-09-26       Impact factor: 2.835

8.  A TR-FRET-based functional assay for screening activators of CARM1.

Authors:  Hao Zeng; Jiacai Wu; Mark T Bedford; Gianluca Sbardella; F Michael Hoffmann; Kun Bi; Wei Xu
Journal:  Chembiochem       Date:  2013-04-12       Impact factor: 3.164

Review 9.  Histone methylation modifiers in cellular signaling pathways.

Authors:  Hunain Alam; Bingnan Gu; Min Gyu Lee
Journal:  Cell Mol Life Sci       Date:  2015-08-25       Impact factor: 9.261

10.  Transcriptional regulation of the human ferritin gene by coordinated regulation of Nrf2 and protein arginine methyltransferases PRMT1 and PRMT4.

Authors:  Bo-Wen Huang; Paul D Ray; Kenta Iwasaki; Yoshiaki Tsuji
Journal:  FASEB J       Date:  2013-05-22       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.